Fibromyalgia Trial, Recruiting NCT07583056 Sponsor: Ionclinics & Deionic SL Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07583056
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with fibromyalgia based on standard medical criteria, including having widespread pain in at least 4 out of 5 body regions (not counting jaw, chest, or abdominal pain) for at least 3 months, with symptom scores meeting specific thresholds (confirm with trial site).
  • People who have another diagnosis alongside fibromyalgia, as having other conditions does not automatically prevent participation.
  • People who are on a stable medication plan (including antidepressants or other relevant medicines) — or not on any medication — and who are willing to keep that plan unchanged throughout the study.
  • People who are able to use a small electrical brain stimulation device at home on their own, or with help from a caregiver.
  • People who have access to a phone or computer with a camera for remote check-ins with the study team.
  • People who are willing and able to complete all stages of the study.
  • People who voluntarily agree to take part and sign the study's consent form.

Who may not be able to join:

  • People who have an immune system disorder or another condition that could explain their fibromyalgia symptoms, such as rheumatoid arthritis, lupus, other autoimmune diseases, neurological disorders, or cancer.
  • People who have an unmanaged serious health condition such as heart disease, kidney disease, or liver disease.
  • People who have skin conditions (such as psoriasis or allergic skin reactions) in the areas where the device electrodes would be placed.
  • People who have metal implants in the head, a history of head injuries, or electronic medical devices such as a cochlear implant or pacemaker.
  • People who have had any form of brain stimulation treatment in the past 6 months.
  • People who have a personal or family history of epilepsy.
  • People who have a significant brain or neurological condition, structural brain abnormality, or who have had a stroke affecting relevant brain areas.
  • People who have used drugs or alcohol heavily in the 3 months before the trial or plan to do so during it (nicotine is excluded from this criterion).
  • People who have had changes to their medication in the month before starting the trial.
  • People who are currently involved in legal proceedings or awaiting litigation during the trial period.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ane Miren Gutiérrez Muto, PhD, Ionclinics & Deionics S.L.

Phone: +34960606200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ionclinics & Deionic SL
Registry
ClinicalTrials.gov
Start date
8 July 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Fibromyalgia Impact Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov